Global Cannabis Use Disorder Treatment Supply, Demand and Key Producers, 2023-2029
The global Cannabis Use Disorder Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Cannabis Use Disorder Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cannabis Use Disorder Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cannabis Use Disorder Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cannabis Use Disorder Treatment total market, 2018-2029, (USD Million)
Global Cannabis Use Disorder Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cannabis Use Disorder Treatment total market, key domestic companies and share, (USD Million)
Global Cannabis Use Disorder Treatment revenue by player and market share 2018-2023, (USD Million)
Global Cannabis Use Disorder Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Cannabis Use Disorder Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cannabis Use Disorder Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior and Mallinckrodt, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cannabis Use Disorder Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cannabis Use Disorder Treatment Market, By Region:
1. How big is the global Cannabis Use Disorder Treatment market?
2. What is the demand of the global Cannabis Use Disorder Treatment market?
3. What is the year over year growth of the global Cannabis Use Disorder Treatment market?
4. What is the total value of the global Cannabis Use Disorder Treatment market?
5. Who are the major players in the global Cannabis Use Disorder Treatment market?
6. What are the growth factors driving the market demand?
This report studies the global Cannabis Use Disorder Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cannabis Use Disorder Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cannabis Use Disorder Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cannabis Use Disorder Treatment total market, 2018-2029, (USD Million)
Global Cannabis Use Disorder Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cannabis Use Disorder Treatment total market, key domestic companies and share, (USD Million)
Global Cannabis Use Disorder Treatment revenue by player and market share 2018-2023, (USD Million)
Global Cannabis Use Disorder Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Cannabis Use Disorder Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cannabis Use Disorder Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior and Mallinckrodt, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cannabis Use Disorder Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cannabis Use Disorder Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tobacco/Nicotine and Vaping
- Alcohol
- Marijuana
- Synthetic Cannabinoids
- Others
- Hospitals and Clinics
- Rehabilitation Centers
- Others
- AbbVie
- Alkermes
- BioCorRx
- Cipla Limited
- Dr. Reddy’s Laboratories
- Glenmark Pharmaceuticals Limited
- Intas Pharmaceuticals Limited
- Indivior
- Mallinckrodt
- Noramco
- Orexo AB
- Purdue Pharma
1. How big is the global Cannabis Use Disorder Treatment market?
2. What is the demand of the global Cannabis Use Disorder Treatment market?
3. What is the year over year growth of the global Cannabis Use Disorder Treatment market?
4. What is the total value of the global Cannabis Use Disorder Treatment market?
5. Who are the major players in the global Cannabis Use Disorder Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cannabis Use Disorder Treatment Introduction
1.2 World Cannabis Use Disorder Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cannabis Use Disorder Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Cannabis Use Disorder Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.3 China Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.4 Europe Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.5 Japan Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.6 South Korea Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.7 ASEAN Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.8 India Cannabis Use Disorder Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cannabis Use Disorder Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cannabis Use Disorder Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.2 World Cannabis Use Disorder Treatment Consumption Value by Region
2.2.1 World Cannabis Use Disorder Treatment Consumption Value by Region (2018-2023)
2.2.2 World Cannabis Use Disorder Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.4 China Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.5 Europe Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.6 Japan Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.7 South Korea Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.8 ASEAN Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.9 India Cannabis Use Disorder Treatment Consumption Value (2018-2029)
3 WORLD CANNABIS USE DISORDER TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Cannabis Use Disorder Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cannabis Use Disorder Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cannabis Use Disorder Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Cannabis Use Disorder Treatment in 2022
3.3 Cannabis Use Disorder Treatment Company Evaluation Quadrant
3.4 Cannabis Use Disorder Treatment Market: Overall Company Footprint Analysis
3.4.1 Cannabis Use Disorder Treatment Market: Region Footprint
3.4.2 Cannabis Use Disorder Treatment Market: Company Product Type Footprint
3.4.3 Cannabis Use Disorder Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cannabis Use Disorder Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cannabis Use Disorder Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cannabis Use Disorder Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cannabis Use Disorder Treatment Consumption Value Comparison
4.2.1 United States VS China: Cannabis Use Disorder Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cannabis Use Disorder Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cannabis Use Disorder Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Cannabis Use Disorder Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023)
4.4 China Based Companies Cannabis Use Disorder Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Cannabis Use Disorder Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023)
4.5 Rest of World Based Cannabis Use Disorder Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cannabis Use Disorder Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cannabis Use Disorder Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tobacco/Nicotine and Vaping
5.2.2 Alcohol
5.2.3 Marijuana
5.2.4 Synthetic Cannabinoids
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Cannabis Use Disorder Treatment Market Size by Type (2018-2023)
5.3.2 World Cannabis Use Disorder Treatment Market Size by Type (2024-2029)
5.3.3 World Cannabis Use Disorder Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cannabis Use Disorder Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals and Clinics
6.2.2 Rehabilitation Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Cannabis Use Disorder Treatment Market Size by Application (2018-2023)
6.3.2 World Cannabis Use Disorder Treatment Market Size by Application (2024-2029)
6.3.3 World Cannabis Use Disorder Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Cannabis Use Disorder Treatment Product and Services
7.1.4 AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Alkermes
7.2.1 Alkermes Details
7.2.2 Alkermes Major Business
7.2.3 Alkermes Cannabis Use Disorder Treatment Product and Services
7.2.4 Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Alkermes Recent Developments/Updates
7.2.6 Alkermes Competitive Strengths & Weaknesses
7.3 BioCorRx
7.3.1 BioCorRx Details
7.3.2 BioCorRx Major Business
7.3.3 BioCorRx Cannabis Use Disorder Treatment Product and Services
7.3.4 BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BioCorRx Recent Developments/Updates
7.3.6 BioCorRx Competitive Strengths & Weaknesses
7.4 Cipla Limited
7.4.1 Cipla Limited Details
7.4.2 Cipla Limited Major Business
7.4.3 Cipla Limited Cannabis Use Disorder Treatment Product and Services
7.4.4 Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Cipla Limited Recent Developments/Updates
7.4.6 Cipla Limited Competitive Strengths & Weaknesses
7.5 Dr. Reddy’s Laboratories
7.5.1 Dr. Reddy’s Laboratories Details
7.5.2 Dr. Reddy’s Laboratories Major Business
7.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Services
7.5.4 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates
7.5.6 Dr. Reddy’s Laboratories Competitive Strengths & Weaknesses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Glenmark Pharmaceuticals Limited Details
7.6.2 Glenmark Pharmaceuticals Limited Major Business
7.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Services
7.6.4 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Glenmark Pharmaceuticals Limited Recent Developments/Updates
7.6.6 Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.7 Intas Pharmaceuticals Limited
7.7.1 Intas Pharmaceuticals Limited Details
7.7.2 Intas Pharmaceuticals Limited Major Business
7.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Services
7.7.4 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Intas Pharmaceuticals Limited Recent Developments/Updates
7.7.6 Intas Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.8 Indivior
7.8.1 Indivior Details
7.8.2 Indivior Major Business
7.8.3 Indivior Cannabis Use Disorder Treatment Product and Services
7.8.4 Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Indivior Recent Developments/Updates
7.8.6 Indivior Competitive Strengths & Weaknesses
7.9 Mallinckrodt
7.9.1 Mallinckrodt Details
7.9.2 Mallinckrodt Major Business
7.9.3 Mallinckrodt Cannabis Use Disorder Treatment Product and Services
7.9.4 Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Mallinckrodt Recent Developments/Updates
7.9.6 Mallinckrodt Competitive Strengths & Weaknesses
7.10 Noramco
7.10.1 Noramco Details
7.10.2 Noramco Major Business
7.10.3 Noramco Cannabis Use Disorder Treatment Product and Services
7.10.4 Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Noramco Recent Developments/Updates
7.10.6 Noramco Competitive Strengths & Weaknesses
7.11 Orexo AB
7.11.1 Orexo AB Details
7.11.2 Orexo AB Major Business
7.11.3 Orexo AB Cannabis Use Disorder Treatment Product and Services
7.11.4 Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Orexo AB Recent Developments/Updates
7.11.6 Orexo AB Competitive Strengths & Weaknesses
7.12 Purdue Pharma
7.12.1 Purdue Pharma Details
7.12.2 Purdue Pharma Major Business
7.12.3 Purdue Pharma Cannabis Use Disorder Treatment Product and Services
7.12.4 Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Purdue Pharma Recent Developments/Updates
7.12.6 Purdue Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cannabis Use Disorder Treatment Industry Chain
8.2 Cannabis Use Disorder Treatment Upstream Analysis
8.3 Cannabis Use Disorder Treatment Midstream Analysis
8.4 Cannabis Use Disorder Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cannabis Use Disorder Treatment Introduction
1.2 World Cannabis Use Disorder Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cannabis Use Disorder Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Cannabis Use Disorder Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.3 China Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.4 Europe Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.5 Japan Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.6 South Korea Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.7 ASEAN Cannabis Use Disorder Treatment Market Size (2018-2029)
1.3.8 India Cannabis Use Disorder Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cannabis Use Disorder Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cannabis Use Disorder Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.2 World Cannabis Use Disorder Treatment Consumption Value by Region
2.2.1 World Cannabis Use Disorder Treatment Consumption Value by Region (2018-2023)
2.2.2 World Cannabis Use Disorder Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.4 China Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.5 Europe Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.6 Japan Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.7 South Korea Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.8 ASEAN Cannabis Use Disorder Treatment Consumption Value (2018-2029)
2.9 India Cannabis Use Disorder Treatment Consumption Value (2018-2029)
3 WORLD CANNABIS USE DISORDER TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Cannabis Use Disorder Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cannabis Use Disorder Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cannabis Use Disorder Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Cannabis Use Disorder Treatment in 2022
3.3 Cannabis Use Disorder Treatment Company Evaluation Quadrant
3.4 Cannabis Use Disorder Treatment Market: Overall Company Footprint Analysis
3.4.1 Cannabis Use Disorder Treatment Market: Region Footprint
3.4.2 Cannabis Use Disorder Treatment Market: Company Product Type Footprint
3.4.3 Cannabis Use Disorder Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cannabis Use Disorder Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cannabis Use Disorder Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cannabis Use Disorder Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cannabis Use Disorder Treatment Consumption Value Comparison
4.2.1 United States VS China: Cannabis Use Disorder Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cannabis Use Disorder Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cannabis Use Disorder Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Cannabis Use Disorder Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023)
4.4 China Based Companies Cannabis Use Disorder Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Cannabis Use Disorder Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023)
4.5 Rest of World Based Cannabis Use Disorder Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cannabis Use Disorder Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cannabis Use Disorder Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tobacco/Nicotine and Vaping
5.2.2 Alcohol
5.2.3 Marijuana
5.2.4 Synthetic Cannabinoids
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Cannabis Use Disorder Treatment Market Size by Type (2018-2023)
5.3.2 World Cannabis Use Disorder Treatment Market Size by Type (2024-2029)
5.3.3 World Cannabis Use Disorder Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cannabis Use Disorder Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals and Clinics
6.2.2 Rehabilitation Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Cannabis Use Disorder Treatment Market Size by Application (2018-2023)
6.3.2 World Cannabis Use Disorder Treatment Market Size by Application (2024-2029)
6.3.3 World Cannabis Use Disorder Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Cannabis Use Disorder Treatment Product and Services
7.1.4 AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Alkermes
7.2.1 Alkermes Details
7.2.2 Alkermes Major Business
7.2.3 Alkermes Cannabis Use Disorder Treatment Product and Services
7.2.4 Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Alkermes Recent Developments/Updates
7.2.6 Alkermes Competitive Strengths & Weaknesses
7.3 BioCorRx
7.3.1 BioCorRx Details
7.3.2 BioCorRx Major Business
7.3.3 BioCorRx Cannabis Use Disorder Treatment Product and Services
7.3.4 BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BioCorRx Recent Developments/Updates
7.3.6 BioCorRx Competitive Strengths & Weaknesses
7.4 Cipla Limited
7.4.1 Cipla Limited Details
7.4.2 Cipla Limited Major Business
7.4.3 Cipla Limited Cannabis Use Disorder Treatment Product and Services
7.4.4 Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Cipla Limited Recent Developments/Updates
7.4.6 Cipla Limited Competitive Strengths & Weaknesses
7.5 Dr. Reddy’s Laboratories
7.5.1 Dr. Reddy’s Laboratories Details
7.5.2 Dr. Reddy’s Laboratories Major Business
7.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Services
7.5.4 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates
7.5.6 Dr. Reddy’s Laboratories Competitive Strengths & Weaknesses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Glenmark Pharmaceuticals Limited Details
7.6.2 Glenmark Pharmaceuticals Limited Major Business
7.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Services
7.6.4 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Glenmark Pharmaceuticals Limited Recent Developments/Updates
7.6.6 Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.7 Intas Pharmaceuticals Limited
7.7.1 Intas Pharmaceuticals Limited Details
7.7.2 Intas Pharmaceuticals Limited Major Business
7.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Services
7.7.4 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Intas Pharmaceuticals Limited Recent Developments/Updates
7.7.6 Intas Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.8 Indivior
7.8.1 Indivior Details
7.8.2 Indivior Major Business
7.8.3 Indivior Cannabis Use Disorder Treatment Product and Services
7.8.4 Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Indivior Recent Developments/Updates
7.8.6 Indivior Competitive Strengths & Weaknesses
7.9 Mallinckrodt
7.9.1 Mallinckrodt Details
7.9.2 Mallinckrodt Major Business
7.9.3 Mallinckrodt Cannabis Use Disorder Treatment Product and Services
7.9.4 Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Mallinckrodt Recent Developments/Updates
7.9.6 Mallinckrodt Competitive Strengths & Weaknesses
7.10 Noramco
7.10.1 Noramco Details
7.10.2 Noramco Major Business
7.10.3 Noramco Cannabis Use Disorder Treatment Product and Services
7.10.4 Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Noramco Recent Developments/Updates
7.10.6 Noramco Competitive Strengths & Weaknesses
7.11 Orexo AB
7.11.1 Orexo AB Details
7.11.2 Orexo AB Major Business
7.11.3 Orexo AB Cannabis Use Disorder Treatment Product and Services
7.11.4 Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Orexo AB Recent Developments/Updates
7.11.6 Orexo AB Competitive Strengths & Weaknesses
7.12 Purdue Pharma
7.12.1 Purdue Pharma Details
7.12.2 Purdue Pharma Major Business
7.12.3 Purdue Pharma Cannabis Use Disorder Treatment Product and Services
7.12.4 Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Purdue Pharma Recent Developments/Updates
7.12.6 Purdue Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cannabis Use Disorder Treatment Industry Chain
8.2 Cannabis Use Disorder Treatment Upstream Analysis
8.3 Cannabis Use Disorder Treatment Midstream Analysis
8.4 Cannabis Use Disorder Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cannabis Use Disorder Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cannabis Use Disorder Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cannabis Use Disorder Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cannabis Use Disorder Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cannabis Use Disorder Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cannabis Use Disorder Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cannabis Use Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cannabis Use Disorder Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cannabis Use Disorder Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cannabis Use Disorder Treatment Players in 2022
Table 12. World Cannabis Use Disorder Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cannabis Use Disorder Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Cannabis Use Disorder Treatment Player
Table 15. Cannabis Use Disorder Treatment Market: Company Product Type Footprint
Table 16. Cannabis Use Disorder Treatment Market: Company Product Application Footprint
Table 17. Cannabis Use Disorder Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Cannabis Use Disorder Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cannabis Use Disorder Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cannabis Use Disorder Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cannabis Use Disorder Treatment Revenue Market Share (2018-2023)
Table 23. China Based Cannabis Use Disorder Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cannabis Use Disorder Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cannabis Use Disorder Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cannabis Use Disorder Treatment Revenue Market Share (2018-2023)
Table 29. World Cannabis Use Disorder Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cannabis Use Disorder Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cannabis Use Disorder Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cannabis Use Disorder Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cannabis Use Disorder Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cannabis Use Disorder Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. AbbVie Basic Information, Area Served and Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Cannabis Use Disorder Treatment Product and Services
Table 38. AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. AbbVie Recent Developments/Updates
Table 40. AbbVie Competitive Strengths & Weaknesses
Table 41. Alkermes Basic Information, Area Served and Competitors
Table 42. Alkermes Major Business
Table 43. Alkermes Cannabis Use Disorder Treatment Product and Services
Table 44. Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Alkermes Recent Developments/Updates
Table 46. Alkermes Competitive Strengths & Weaknesses
Table 47. BioCorRx Basic Information, Area Served and Competitors
Table 48. BioCorRx Major Business
Table 49. BioCorRx Cannabis Use Disorder Treatment Product and Services
Table 50. BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BioCorRx Recent Developments/Updates
Table 52. BioCorRx Competitive Strengths & Weaknesses
Table 53. Cipla Limited Basic Information, Area Served and Competitors
Table 54. Cipla Limited Major Business
Table 55. Cipla Limited Cannabis Use Disorder Treatment Product and Services
Table 56. Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Cipla Limited Recent Developments/Updates
Table 58. Cipla Limited Competitive Strengths & Weaknesses
Table 59. Dr. Reddy’s Laboratories Basic Information, Area Served and Competitors
Table 60. Dr. Reddy’s Laboratories Major Business
Table 61. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Services
Table 62. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 64. Dr. Reddy’s Laboratories Competitive Strengths & Weaknesses
Table 65. Glenmark Pharmaceuticals Limited Basic Information, Area Served and Competitors
Table 66. Glenmark Pharmaceuticals Limited Major Business
Table 67. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Services
Table 68. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 70. Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 71. Intas Pharmaceuticals Limited Basic Information, Area Served and Competitors
Table 72. Intas Pharmaceuticals Limited Major Business
Table 73. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Services
Table 74. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Intas Pharmaceuticals Limited Recent Developments/Updates
Table 76. Intas Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 77. Indivior Basic Information, Area Served and Competitors
Table 78. Indivior Major Business
Table 79. Indivior Cannabis Use Disorder Treatment Product and Services
Table 80. Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Indivior Recent Developments/Updates
Table 82. Indivior Competitive Strengths & Weaknesses
Table 83. Mallinckrodt Basic Information, Area Served and Competitors
Table 84. Mallinckrodt Major Business
Table 85. Mallinckrodt Cannabis Use Disorder Treatment Product and Services
Table 86. Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Mallinckrodt Recent Developments/Updates
Table 88. Mallinckrodt Competitive Strengths & Weaknesses
Table 89. Noramco Basic Information, Area Served and Competitors
Table 90. Noramco Major Business
Table 91. Noramco Cannabis Use Disorder Treatment Product and Services
Table 92. Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Noramco Recent Developments/Updates
Table 94. Noramco Competitive Strengths & Weaknesses
Table 95. Orexo AB Basic Information, Area Served and Competitors
Table 96. Orexo AB Major Business
Table 97. Orexo AB Cannabis Use Disorder Treatment Product and Services
Table 98. Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Orexo AB Recent Developments/Updates
Table 100. Purdue Pharma Basic Information, Area Served and Competitors
Table 101. Purdue Pharma Major Business
Table 102. Purdue Pharma Cannabis Use Disorder Treatment Product and Services
Table 103. Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Cannabis Use Disorder Treatment Upstream (Raw Materials)
Table 105. Cannabis Use Disorder Treatment Typical Customers
Table 1. World Cannabis Use Disorder Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cannabis Use Disorder Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cannabis Use Disorder Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cannabis Use Disorder Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cannabis Use Disorder Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cannabis Use Disorder Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cannabis Use Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cannabis Use Disorder Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cannabis Use Disorder Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cannabis Use Disorder Treatment Players in 2022
Table 12. World Cannabis Use Disorder Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cannabis Use Disorder Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Cannabis Use Disorder Treatment Player
Table 15. Cannabis Use Disorder Treatment Market: Company Product Type Footprint
Table 16. Cannabis Use Disorder Treatment Market: Company Product Application Footprint
Table 17. Cannabis Use Disorder Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Cannabis Use Disorder Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cannabis Use Disorder Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cannabis Use Disorder Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cannabis Use Disorder Treatment Revenue Market Share (2018-2023)
Table 23. China Based Cannabis Use Disorder Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cannabis Use Disorder Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cannabis Use Disorder Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cannabis Use Disorder Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cannabis Use Disorder Treatment Revenue Market Share (2018-2023)
Table 29. World Cannabis Use Disorder Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cannabis Use Disorder Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cannabis Use Disorder Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cannabis Use Disorder Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cannabis Use Disorder Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cannabis Use Disorder Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. AbbVie Basic Information, Area Served and Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Cannabis Use Disorder Treatment Product and Services
Table 38. AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. AbbVie Recent Developments/Updates
Table 40. AbbVie Competitive Strengths & Weaknesses
Table 41. Alkermes Basic Information, Area Served and Competitors
Table 42. Alkermes Major Business
Table 43. Alkermes Cannabis Use Disorder Treatment Product and Services
Table 44. Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Alkermes Recent Developments/Updates
Table 46. Alkermes Competitive Strengths & Weaknesses
Table 47. BioCorRx Basic Information, Area Served and Competitors
Table 48. BioCorRx Major Business
Table 49. BioCorRx Cannabis Use Disorder Treatment Product and Services
Table 50. BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BioCorRx Recent Developments/Updates
Table 52. BioCorRx Competitive Strengths & Weaknesses
Table 53. Cipla Limited Basic Information, Area Served and Competitors
Table 54. Cipla Limited Major Business
Table 55. Cipla Limited Cannabis Use Disorder Treatment Product and Services
Table 56. Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Cipla Limited Recent Developments/Updates
Table 58. Cipla Limited Competitive Strengths & Weaknesses
Table 59. Dr. Reddy’s Laboratories Basic Information, Area Served and Competitors
Table 60. Dr. Reddy’s Laboratories Major Business
Table 61. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Services
Table 62. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 64. Dr. Reddy’s Laboratories Competitive Strengths & Weaknesses
Table 65. Glenmark Pharmaceuticals Limited Basic Information, Area Served and Competitors
Table 66. Glenmark Pharmaceuticals Limited Major Business
Table 67. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Services
Table 68. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 70. Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 71. Intas Pharmaceuticals Limited Basic Information, Area Served and Competitors
Table 72. Intas Pharmaceuticals Limited Major Business
Table 73. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Services
Table 74. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Intas Pharmaceuticals Limited Recent Developments/Updates
Table 76. Intas Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 77. Indivior Basic Information, Area Served and Competitors
Table 78. Indivior Major Business
Table 79. Indivior Cannabis Use Disorder Treatment Product and Services
Table 80. Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Indivior Recent Developments/Updates
Table 82. Indivior Competitive Strengths & Weaknesses
Table 83. Mallinckrodt Basic Information, Area Served and Competitors
Table 84. Mallinckrodt Major Business
Table 85. Mallinckrodt Cannabis Use Disorder Treatment Product and Services
Table 86. Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Mallinckrodt Recent Developments/Updates
Table 88. Mallinckrodt Competitive Strengths & Weaknesses
Table 89. Noramco Basic Information, Area Served and Competitors
Table 90. Noramco Major Business
Table 91. Noramco Cannabis Use Disorder Treatment Product and Services
Table 92. Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Noramco Recent Developments/Updates
Table 94. Noramco Competitive Strengths & Weaknesses
Table 95. Orexo AB Basic Information, Area Served and Competitors
Table 96. Orexo AB Major Business
Table 97. Orexo AB Cannabis Use Disorder Treatment Product and Services
Table 98. Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Orexo AB Recent Developments/Updates
Table 100. Purdue Pharma Basic Information, Area Served and Competitors
Table 101. Purdue Pharma Major Business
Table 102. Purdue Pharma Cannabis Use Disorder Treatment Product and Services
Table 103. Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Cannabis Use Disorder Treatment Upstream (Raw Materials)
Table 105. Cannabis Use Disorder Treatment Typical Customers
LIST OF FIGURES
Figure 1. Cannabis Use Disorder Treatment Picture
Figure 2. World Cannabis Use Disorder Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cannabis Use Disorder Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cannabis Use Disorder Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cannabis Use Disorder Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Cannabis Use Disorder Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cannabis Use Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cannabis Use Disorder Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cannabis Use Disorder Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cannabis Use Disorder Treatment Markets in 2022
Figure 27. United States VS China: Cannabis Use Disorder Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cannabis Use Disorder Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cannabis Use Disorder Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cannabis Use Disorder Treatment Market Size Market Share by Type in 2022
Figure 31. Tobacco/Nicotine and Vaping
Figure 32. Alcohol
Figure 33. Marijuana
Figure 34. Synthetic Cannabinoids
Figure 35. Others
Figure 36. World Cannabis Use Disorder Treatment Market Size Market Share by Type (2018-2029)
Figure 37. World Cannabis Use Disorder Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Cannabis Use Disorder Treatment Market Size Market Share by Application in 2022
Figure 39. Hospitals and Clinics
Figure 40. Rehabilitation Centers
Figure 41. Others
Figure 42. Cannabis Use Disorder Treatment Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Cannabis Use Disorder Treatment Picture
Figure 2. World Cannabis Use Disorder Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cannabis Use Disorder Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cannabis Use Disorder Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cannabis Use Disorder Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cannabis Use Disorder Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Cannabis Use Disorder Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cannabis Use Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cannabis Use Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cannabis Use Disorder Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cannabis Use Disorder Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cannabis Use Disorder Treatment Markets in 2022
Figure 27. United States VS China: Cannabis Use Disorder Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cannabis Use Disorder Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cannabis Use Disorder Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cannabis Use Disorder Treatment Market Size Market Share by Type in 2022
Figure 31. Tobacco/Nicotine and Vaping
Figure 32. Alcohol
Figure 33. Marijuana
Figure 34. Synthetic Cannabinoids
Figure 35. Others
Figure 36. World Cannabis Use Disorder Treatment Market Size Market Share by Type (2018-2029)
Figure 37. World Cannabis Use Disorder Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Cannabis Use Disorder Treatment Market Size Market Share by Application in 2022
Figure 39. Hospitals and Clinics
Figure 40. Rehabilitation Centers
Figure 41. Others
Figure 42. Cannabis Use Disorder Treatment Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
